HDFC Life Insurance Company Limited

NSE: HDFCLIFE · Financial Services · Lot size: 1100

HDFC Life Insurance Company Limited Open Interest & PCR Analysis

574.8Updated 5 Jun 2026, 03:30 pm IST
PCR
0.64
Bearish signal
Max Pain
600
Spot below by ₹25
Total CE OI
18.50M
Call writers
Total PE OI
11.85M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-06-05

Frequently Asked Questions

What is HDFC Life Insurance Company Limited PCR (Put-Call Ratio) today?
HDFC Life Insurance Company Limited's current PCR is 0.64. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. HDFC Life Insurance Company Limited's PCR of 0.64 indicates bearish sentiment.
What is HDFC Life Insurance Company Limited OI buildup type today?
HDFC Life Insurance Company Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for HDFC Life Insurance Company Limited?
HDFC Life Insurance Company Limited has total CE (call) OI of 18496500 contracts and total PE (put) OI of 11852500 contracts for the nearest expiry. The PCR is 0.64.
How is open interest analysis useful for HDFC Life Insurance Company Limited trading?
OI analysis for HDFC Life Insurance Company Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for HDFC Life Insurance Company Limited?
HDFC Life Insurance Company Limited's max pain is ₹600 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.